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Screening for Bacterial Vaginosis
The IIDSOG-USA has advocated antepartum screening for bacterial vaginosis
(BV) in all pregnant women in an attempt to prevent premature delivery. The
point is well made that there are a number of screening tests routinely performed
during pregnancy that may or may not be beneficial.
The question of whether or not routine screening for BV has merit with regard
to prevention of premature labor and delivery remains to be answered. McDonald
et al. published the results of a double-blind study of metronidazole versus placebo
treatment of pregnant women known to have BV. They found no difference
between metronidazole and placebo with regard to preterm birth or spontaneous
preterm birth. However, they did find that, in a subset of women who had a
previous preterm birth, metronidazole was effective in reducing preterm birth
when compared with placebo.
Perhaps the group to focus on is those individuals who have had a previous
preterm birth and are found to have BV in the current pregnancy. Often, recom-
mendations for treatment are put forth without a sufficient knowledge base re-
garding cause and effect. The infectious disease societies should not be quick to
embrace a treatment; rather, they should encourage the pharmaceutical industry to
fund studies that are directed at explaining the pathophysiology. In this way,
treatments can be developed that actually address the problem. Bacterial vaginosis
represents an entity that investigators consider to be a disruption in the vaginal
microflora. However, the pharmaceutical industry approaches BV as an infection
treatable by the administration of an antibiotic. The fact that there is a significant
recurrence rate has not been addressed. It is time that the investigators address the
total management of the patient with BV.
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